Sanofi India Q2 net up 12% at Rs 64.2 crore

NEW DELHI: Drug firm Sanofi India today reported a 11.65 per cent rise in its standalone net profit at Rs 64.2 crore during second quarter ended June 30, 2015.

The company, which follows January-December financial year, had posted a net profit of Rs 57.5 crore in the corresponding period of the previous fiscal.

Standalone total income from operations also rose to Rs 549.7 crore for the quarter ended June 30, 2015 as against Rs 505.8 crore for the same period year ago, Sanofi India said in a filing to the BSE.

In a separate filing to the BSE, Sanofi India said its board of directors has declared an interim dividend of Rs 18 per equity share of Rs 10 for the financial year ended December 31, 2015.

The Board has also approved of the company selling its commercial property, being land along with building known as ' Aventis House' standing thereon, situated at Sir Mathuradas Vasanji Road, Andheri (East) Mumbai for consideration of Rs 111 crore, it added.

Shares of Sanofi India today closed at Rs 3,517.80 per scrip on BSE, down 0.89 per cent from previous close.